Introduction
============

Injury and infection priming is a memory-like response that is reportedly elicited in several (but not all) insect groups by bacteria, fungi, viruses, parasites and even inert molecules (LPS, heat-killed bacteria) ([@B34]; [@B47]; [@B32]; [@B46]; [@B44]; [@B16]; [@B52]; [@B50]; [@B9]). Despite the evidence of a widespread phenomenon, the mechanism(s) and molecule(s) associated with the induction of priming are as yet unclear (but see [@B10]; [@B39]).

There are studies showing that after previous exposure to a pathogen, there was specific protection against a subsequent lethal challenge. For instance, after previous contact of *Drosophila melanogaster* with different bacteria, individuals were able to increase its survival rate and specific phagocytic activity against the corresponding pathogen ([@B37]; [@B9]). While different strains of *Pseudomona aeruginosa* elicit defense-specific genes ([@B1]). *Anopheles gambiae* showed dissimilar responses to *Plasmodium berghei* and *P. falciparum* ([@B43]). However, these studies do not necessarily reveal the specific recognition of a pathogen, but highlights a specificity response degree against different bacteria during priming.

The specificity of the response against infectious agents can promote an expedited immune activation leading to elimination or control of the invader. The energetic cost of a specific response could be lower than that of a generic immune response or one that is continuously activated ([@B38]). Consequently, the resources spared by the use of a specific immune response can be used for the expression of other traits linked with survival and reproduction.

There has been criticism of the reports posing that previous contact with an infectious agent can afford an insect with improved immunity against a second exposure to the same pathogen. The specificity of the insect memory-like immune response is rejected by some researchers (see [@B15]) because of the lack of antibodies as well as clonal expansion and differentiation. Nonetheless, the immune system of insects comprises a number of humoral (soluble and membrane-associated) recognition receptors PRRs ([@B21]; [@B49]). Moreover, the DSCAM is a PRR that can take thousands of different forms through alternative splicing ([@B54]; [@B2]). In *A. gambiae*, Dscam (AgDscam) is capable of producing pathogen specific splice form repertoires upon bacteria (Gram+ and Gram-) and *Plasmodium* infection ([@B12]). Dscam plays a role mainly as an opsonization molecule with an increased affinity to the infectious organisms ([@B12]; [@B48]).

Recognition leads to the activation of three signaling pathways: Toll, IMD and the JAK/STAT ([@B21]). In *Drosophila*, these pathways can induce a differential expression of AMPs following a bacterial challenge ([@B23]; [@B1]). The differential recognition of pathogens and production of effectors indicates a certain degree of specificity of the immune system.

Puzzlingly, not all insects seem to show this differential activation and regulation of immune pathways. For example, in *Aedes aegypti* cellular and melanization responses are independent of the bacterial Gram type (see [@B20]). Even more, some AMPs depend on two pathways ([@B24]). At first glance, it could seem unlikely that selective AMP production provides an explanation for the subsequent specific protection in some insects. After all, when dipterans are re-infected, their immunity is mediated by granulocytes ([@B37]; [@B43]). This through prohemocyte differentiation that increased the granulocyte population and trigger changes in the morphology and binding properties of these cells ([@B43]), thus conferring enhanced immunity to following parasite infections.

However, there are signaling pathways required for hemocytes to differentiate in response to one or more differentiation factors ([@B43]; [@B40], [@B39]). Immune pathways of hemocytes are activated after pathogen recognition or humoral stimulation, which leads to the production and release of signaling and/or effector molecules, including AMPs ([@B3]). Hemocytes can also induce AMP expression in other tissues, such as fat body (a tissue with great AMP production) ([@B22]). Consequently, it is plausible that increased cellular activity upon reinfection could have an effect on AMP production. In this sense, [@B10] compared two groups of *A. albimanus* in contact with *P. berghei*. One had had prior contact with this pathogen and the other had not. There was greater AMP transcription in the previously infected mosquitoes. Therefore, it is probable that injury and infection priming entails specific cellular and humoral products, possibly interconnected with each other.

Previous studies have reported injury and infection priming in *A. aegypti* mosquito ([@B28]; [@B6]; [@B31]), revealing the role of immune pathways and the participation of AMPs in memory-like responses, meaning the ability to enhance or intensify the effectiveness of the immune response after a previous contact with an elicitor of the immune response. However, priming was analyzed by using consecutive challenges with the same pathogen, but without directly testing the specificity of the response. It is important to determine the specificity of the immune response in insects, because the selective pressures exerted by different pathogens could be reflected in their immune strategies.

For this reason, the aim of the present study was to determine whether previous exposure to bacteria enhanced the survival of *A. aegypti* and/or led to greater AMP expression after a second exposure to the same or a distinct bacteria. For infections, *Escherichia coli* (Gram-) and *Staphylococcus aureus* (Gram+) were used as pathogen models. We documented AMP transcription at three different designated time points after a non-lethal dose (priming induction) and at another three time points following a second exposure 7 days post-priming (**Figure [1](#F1){ref-type="fig"}**). With this design, we tried to avoid overlap of the second challenge with the response generated by the priming dose.

![**Experimental design of *Aedes aegypti* immune priming challenge (first injection) and lethal challenge (second injection), using homologous and heterologous challenges with *Escherichia coli*, *Staphylococcus aureus*, and RPMI medium only**.](fmicb-07-00975-g001){#F1}

The results demonstrate an increased survival of the mosquitoes previously immunized with a low dose of *E. coli*, but not with *S. aureus*. Although this protection was not specific, differential AMP expression proved to be elicited by each bacterium. We discuss these results in light of the SPI epidemiological model developed by [@B51] and [@B5]. In this model, pathogen virulence, associated host damage, and the host capacity of pathogen recognition have an essential role in the evolution of memory-like responses (priming).

Materials and Methods {#s1}
=====================

Female adult mosquitoes 3--5 days old were used for the experiments. They were reared under insectary conditions (12:12 h light/dark cycle at 25--28°C) at the Instituto National de Salud Pública (INSP), Mexico. The microbial strains employed for infection were the Gram+ bacterium *S. aureus* (the 1MR strain, which is methicillin and oxacillin-resistant, kindly donated by Dr. María Elena Velázquez, INSP) and the Gram- bacterium *E. coli* (the 01268 strain, which is ampicillin resistant, kindly donated by Dr. Jesús Silva, INSP). To reach the exponential growth phase, the two bacteria were incubated in LB-broth at 37°C (200 RPMI), the first for 4 h and the second for 3.15 h (for both bacteria final OD~600~ ≈ 0.350).

Priming and Lethal Doses
------------------------

The priming doses (LD~0~) were 2500 CFU/μl for *S. aureus* and 1300 CFU/μl for *E. coli*. For the lethal challenge (LD~30~), we used a higher dose of *E. coli* (18 × 10^3^ CFU/μl) and *S. aureus* (33 × 10^3^ CFU/μl). These doses were previously determined by injecting separate groups of mosquitoes with serial dilutions of each bacterium. We used RPMI (GIBCO-Na~2~CO~3~, 300 mg/L [L]{.smallcaps}-glutamine) as a vehicle for the bacterial injections. This medium was used as a vehicle because mosquito mortality attributable to injection is reduced with this cell culture medium when compared to Schneider and Grace's insect medium (*Log-rank x*^2^= 131.006, *P* \< 0.001), while no significant difference between PBS, Saline solution (0.9% NaCl) and MEM medium (*Log-rank x*^2^= 1.075--9.18, *P* \> 0.05) (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}) was observed. RPMI has been used in other studies (see [@B19]; [@B17],[@B18]; [@B31]).

Injections
----------

Mosquitoes were cold (4°C) anesthetized and injected using a pulled glass needle attached to a Drummond Captrol III microinjector. The injection was applied in the abdomen close to the junction of the ventral and dorsal cuticles, volume injected about ≈ 0.1 μl per mosquito. After injections, mosquitoes were transferred to the insectary and maintained on *ad libitum* sucrose solution.

Experimental Design
-------------------

We first injected two groups of mosquitoes (*n* = 200) with a sublethal dose (LD~0~), using either *S. aureus* or *E. coli* (**Figure [1](#F1){ref-type="fig"}**) to trigger injury and infection priming. A third group (the positive control, *n* = 300) was injected with RPMI only (**Figure [1](#F1){ref-type="fig"}**). The negative control group (*n* = 100) was only cold anesthetized for 10 min.

We challenged the mosquitoes with the LD~30~ dose 7 days after the primary exposure (**Figure [1](#F1){ref-type="fig"}**). For this second exposure, half of the *E. coli* primed mosquitoes (*n* = 100) were injected with *E. coli* (the *E. coli--E. coli* group) and the other half (*n* = 100) with *S. aureus* (the *E. coli--S. aureus* group) in order to explore the specificity of the response. Likewise, half of the *S. aureus* primed group (*n* = 100) was given a second injection with *S. aureus* (the *S. aureus--S. aureus* group) and the other half (*n* = 100) with *E. coli* (the *S. aureus--E. coli* group) in order to explore the specificity of the response. The RPMI injected mosquitoes were divided into three groups for the second injection: the first was administered *E. coli* (the RPMI-*E. coli* group, *n* = 100), the second *S. aureus* (the RPMI-*S. aureus* group, *n* = 100), and the third RPMI only (the RPMI--RPMI group, *n* = 100; the positive control) (**Figure [1](#F1){ref-type="fig"}**). The negative control group (C) was only cold anesthetized again for 10 min.

Survival of Adults after the Lethal Challenge
---------------------------------------------

After the lethal challenge (second injection), survival was recorded for 29 days. A *Log-rank x*^2^ test was used to detect differences in survival curves between primed (with the same or a different bacterium), unprimed and control groups. The analysis was undertaken using JMP 7.0 (SAS Institute, 2007). Three different biological repetitions were developed.

Antimicrobial Peptide Transcript Dynamics (qRT-PCR Analyses)
------------------------------------------------------------

Before the priming-induction injection and at 10 h, 24 h, and 7 days post-priming (first injection), ten mosquitoes from each group were collected and stored at -70°C to await processing. Likewise, at 10 h, 24 h, and 7 days post-lethal challenge (second injection), ten mosquitoes from each group were collected and stored at -70°C until processed.

Total RNA was extracted from each of the groups using 500 μl Trizol reagent (*Invitrogen*) and RNA concentration was measured using Nanodrop. We used 500 ng/μl of the total RNA for cDNA synthesis using the RevertAid Premium Reverse Transcriptase (*Thermo Scientific*). The resultant cDNA was quantified and well-adjusted a 500 ng/μl, and 1μl was used for real-time quantitative PCR reactions. The qPCR reaction was performed using gene-specific primers for cecropin (*CEC* Id: AAEL015515-RA, 160 pb; forward 5′ TCA CAA AGT TAT TTC TCC TGA TCG 3′; reverse 5′ GCT TTA GCC CCA GCT ACA AC 3′), attacin (*ATA* Id: AAEL003389-RA, 231 pb; forward 5′ TTG GCA GGC ACG GAA TGT CTT G 3′; reverse 5′ TGT TGT CGG GAC CGG GAA GTG 3′), defensin (*DEF* Id: AAEL003832-RA, 200 pb; forward 5′ TTG TTT GCT TCG TTG CTC TTT 3′; reverse 5′ ATC TCC TAC ACC GAA CCC ACT 3′) *ribosomal protein S7* (internal control, Id: AAEL009496-RA, 190 pb; forward 5′ GGG ACA AAT CGG CCA GGC TAT C 3′, reverse 5′ TCG TGG ACG CTT CTG CTT GTT G 3′), and Maxima SYBR Green/ROX qPCR Master Mix (*Thermo Scientific*) on a StepOne Plus Real-Time PCR system (*Applied Biosystem*). These sequences were used previously in a priming study with *A. aegypti* ([@B31]).

Relative quantification of mRNA levels was done by the 2*^-ΔΔC^~T~* method, and primer efficiencies were calculated by measuring how the standard *ΔC~T~* varied with template serial dilutions (PCR efficiency is about 95--99% for each AMP). For all trials, the ribosomal protein gene S7 was used as the reference. The levels of *CEC, DEF*, and *ATA* were normalized with respect to the S7 transcript of the same sample. Melting curve analyses confirmed that only cDNA, and not genomic DNA, was amplified. The relative expressions of AMP's were represented in ratios of 0 to 1, because the differences between transcript expressions of AMP were extremely disproportional. Therefore, we homogenize these differences of copy number in ratios for the three AMP genes. Three independent trials were conducted, each analyzed in duplicate.

Differences between groups were analyzed with a one-way ANOVA. Where significant ANOVA differences were found, an LSD-Fisher *post hoc* was implemented to identify the nature of these differences. Values are presented as the mean ± SE. Analyses were carried out using Statistica 7.0 (StatSoft, Inc.).

Results
=======

Survival
--------

The survival analysis revealed that exposure to a low dose of *E. coli* delayed significantly mortality of mosquitos against the lethal challenge of the same bacterium. That is, there was a higher survival rate for the *E. coli--E. coli* than RPMI-*E. coli* group (*Log-rank x*^2^ = 32.143, *P* \< 0.00001) (**Figure [2A](#F2){ref-type="fig"}**). The results are from three different biological repetitions. Moreover, priming with *E. coli* also provided protection against a lethal challenge with *S. aureus* (**Figure [2B](#F2){ref-type="fig"}**).

![**Survival curves for mosquitoes after the second challenge, showing the results when using homologous and heterologous challenges with *E. coli*, *S. aureus* and RPMI medium only. (A)** Second injection with *E. coli* or RPMI medium only, after first injection with *E. coli* or RPMI medium only. **(B)** Second injection with *E. coli*, *S. aureus*, or RPMI medium only, after first injection with *E. coli* or RPMI medium only. **(C)** Second injection with *S. aureus* or RPMI medium only, after first injection with *S. aureus* or RPMI medium only. **(D)** Second injection with *S. aureus*, *E. coli*, or RPMI medium only, after first injection with S. *aureus* or RPMI medium only. Control were mosquitoes that were not treated (cold-only). Data are expressed as the mean ± SE from 3 independent experiments.](fmicb-07-00975-g002){#F2}

However, previous exposure to *S. aureus* did not elicit priming against the lethal challenge with the same bacterium, evidenced by the fact that the survival of the *S. aureus--S. aureus* mosquitoes did not differ from that of the RPMI-*S. aureus* group (*Log-rank x*^2^= 1.014, *P* = 0.602) (**Figure [2C](#F2){ref-type="fig"}**). Furthermore, previous exposure to *S. aureus* did not elicit a protective response against the lethal challenge with *E. coli* (*Log-rank x*^2^= 3.718, *P* = 0.293) (**Figure [2D](#F2){ref-type="fig"}**). Regarding the lethal challenge, *E. coli* showed a greater negative impact on the survival of mosquitoes than *S. aureus*, suggesting that impact of the former probably was continuous through time.

Dynamics of Antimicrobial Peptide Transcripts (Response Induced by *E. coli* Priming)
-------------------------------------------------------------------------------------

Before the first injection, no differences were observed in the relative mRNA levels of transcripts for any of the three peptides (cecropin, attacin or defensin, **Figure [3](#F3){ref-type="fig"}**). Ten hours after the first injection using RPMI or *E. coli*, a slight cecropin relative expression was observed in both cases. Attacin and defensin expression was higher after the first injection using RPMI or *E. coli*, although there were no differences between these two injected groups (RPMI vs. *E. coli*, **Figure [3A](#F3){ref-type="fig"}**). At 24 h post-injection, a decreased expression of the transcripts was observed for both groups, and at the 7th day post-injection values were close to 0.1.

![**Analysis of AMP expression in *A. aegypti* mosquitoes demonstrated an immune response with homologous and heterologous challenges using *E. coli*, *S. aureus*, and RPMI medium only. (A)** Second injection with *E. coli* or RPMI medium only, after first injection with *E. coli* or RPMI medium only. **(B)** Second injection with *E. coli* or *S. aureus*, after first injection with *E. coli*. Control were mosquitoes that were not treated (cold-only). Data are expressed as the mean ± SE from 3 independent experiments.](fmicb-07-00975-g003){#F3}

Compared to the value found after the first injection, 10 h after the lethal challenge (second injection) with *E. coli* (in the *E. coli--E. coli* and RPMI-*E. coli* groups), there was an increased expression of cecropin and defensin (one and fourfold, respectively), with no differences between these two groups (**Figure [3A](#F3){ref-type="fig"}**). Attacin also showed an increased expression, which was higher for the RPMI-*E. coli* than the *E. coli--E. coli* group (LSD *Post hoc*, *P* = 0.002; **Figure [3A](#F3){ref-type="fig"}**; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). For the RPMI--RPMI group, the AMP expression was lower than that found in the other injected groups (**Figure [3A](#F3){ref-type="fig"}**). The increased AMP expression after the second injection can be attributed to the higher *E. coli* dose used for the lethal challenge than for priming. At 24 h post-lethal challenge (second injection), we observed a priming effect with regard to attacin and defensin, evidenced by the higher level of these peptides in the *E. coli--E. coli* than RPMI-*E. coli* group (LSD *post hoc*, *P* = 0.002 and *P* = 0.004, respectively; **Figure [3A](#F3){ref-type="fig"}**). Cecropin showed an increased expression in both these groups, but there was no difference between the *E. coli--E. coli* and RPMI-*E. coli* groups. For the RPMI--RPMI group, the AMP expression remained at a low level compared to the other injected groups. At the 7th day post-lethal challenge, the AMP expression in all groups declined to around 0.2 or 0.1, with no differences detected between groups.

At 10 h, 24 h, and 7 days post-lethal challenge, there were no significant differences in cecropin and defensin expression between the *E. coli--E. coli* and *E. coli--S. aureus* groups (**Figure [3B](#F3){ref-type="fig"}**). However, at 24 h post-lethal challenge, a lower expression of attacin was observed in the *E. coli--S. aureus* than *E. coli--E. coli* group (see **Figure [3B](#F3){ref-type="fig"}**; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). These results suggest a dissimilar AMP expression induced by each bacterium. Defensin and cecropin expression could be correlated with the observed enhanced survival found in both of these groups, while attacin expression only correlated with the survival of the *E. coli--E. coli* group.

Dynamics of the Antimicrobial Peptide Transcripts (Response Induced by *S. aureus* Priming)
-------------------------------------------------------------------------------------------

At 10 h, 24 h, and 7 days post-injection with the low dose of *S. aureus* (first injection), low AMP expression was observed. Attacin and defensin expression was higher than that of cecropin. However, no differences were found between the RPMI and *S. aureus* groups (**Figure [4A](#F4){ref-type="fig"}**). A decreased expression of the transcripts was observed in all groups at 24 h post-injection, reaching values close to 0.1 by the 7th day.

![**Analysis of AMP expression in *A. aegypti* mosquitoes demonstrated an immune response with homologous and heterologous challenges using *E. coli*, *S. aureus* and RPMI medium only. (A)** Second injection with *S. aureus* or RPMI medium only, after first injection with *S. aureus* or RPMI medium only. **(B)** Second injection with *S. aureus* or *E. coli*, after first injection with *S. aureus*. Control were mosquitoes that were not treated (cold-only). Data are expressed as the mean ± SE from 3 independent experiments.](fmicb-07-00975-g004){#F4}

Compared to the expression after the first injection, 10 h after the lethal challenge a significant increase in defensin and a slight increment of cecropin were observed in both the *S. aureus--S. aureus* and RPMI-*S. aureus* groups, with no differences between groups (**Figure [4A](#F4){ref-type="fig"}**). We observed a priming effect at 24 h post-lethal challenge, evidenced by the higher levels of cecropin and defensin found in the *S. aureus--S. aureus* than RPMI-*S. aureus* group (LSD *post hoc*, *P* = 0.001 and *P* = 0.008, respectively; **Figure [4A](#F4){ref-type="fig"}**, Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). No increased expression of attacin was detected at any time point for the RPMI-*S. aureus*, *S. aureus--S. aureus*, or *E. coli--S. aureus* group.

At 10 h post-lethal challenge, there was significantly greater cecropin and defensin expression for the *S. aureus--E. coli* than *S. aureus--S. aureus* group (**Figure [4B](#F4){ref-type="fig"}**; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Likewise, 24 h after the lethal challenge the attacin expression was greater for the *S. aureus--E. coli* than *S. aureus--S. aureus* group (**Figure [4B](#F4){ref-type="fig"}**; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}).

Injection damage (represented by the RPMI--RPMI group, Supplementary Table [S2](#SM1){ref-type="supplementary-material"}) triggered AMP expression. This expression showed the same trend after the first and second injection (**Figure [4A](#F4){ref-type="fig"}**). However, levels of expression after the second injection were below those of the first injection for all groups. This result and the low attacin expression in the *E. coli--S. aureus*, *S. aureus--S. aureus*, and RPMI-*S. aureus* groups suggest that *S. aureus* was unable to induce attacin expression.

Discussion
==========

The present study demonstrates that in females of *A. aegypti*, priming with a low dose of *E. coli* elicited a protective response against a subsequent lethal challenge with the same bacteria or with *S. aureus.* This protective response correlated with the expression of attacin and defensin.

Contrarily, exposure to a low dose of *S. aureus* did not improve the survival of mosquitoes after a lethal challenge with *S. aureus* or *E. coli*. However, there was an increased expression of defensin and cecropin in the group administered a low dose of *S. aureus* followed by a lethal challenge with the same bacterium. Additionally, there was an increased expression not only of defensin and cecropin but also of attacin in heterologous-challenged group (*S. aureus*--*E coli*), indicating that the two bacteria elicited a differential AMP expression. These results suggest a quasi-specificity (*sensu* [@B45]) in AMP expression induced by the lethal challenge.

Although it has been demonstrated that some invertebrates express injury and infection priming (for one or more pathogens), and in some cases specificity of the immune response, evidence in other insect groups reveals that a memory-like response apparently does not exist (e.g., [@B37]; [@B14]; [@B42]; [@B13]; [@B55]). Our results show that *S. aureus* induced priming in terms of the expression level of AMPs, but not in regard to survival. To our knowledge, this is the first report demonstrating this effect.

The non-ubiquitous expression of priming (specific or otherwise) in insects has been explained by the concept of the inducible costs of priming ([@B33]; [@B14]). Likewise, the short life span of some insect groups limits the chance of a secondary encounter with the same pathogen ([@B25]). The SPI model proposes that pathogens producing damage select for greater priming to reduce the negative effects of the infection. But this also depends on the level of protection afforded against future exposure ([@B51]; [@B5]).

In *Galleria mellonella*, ([@B35]) the authors demonstrated the existence of a threshold below which the immune response is aimed at solely containing the infection. Above this threshold, the immune response not only contains the infection but also protects the host from subsequent contact with the same pathogen. Hence, the host is capable of optimally tuning its response by sensing the infection levels. Our results show that after the lethal challenge, *E. coli* had greater impact than *S. aureus* (observed by the higher mortality of the RPMI-*E. coli* and *S. aureus--E. coli* groups), implying a greater chance of damage by this gram- bacteria. Contrarily, the *S. aureus--S. aureus*, RPMI-*S. aureus*, and RPMI--RPMI groups showed similar mortality curves (**Figure [2C](#F2){ref-type="fig"}**). In accordance with the SPI injury and infection priming theory, *E. coli* induced memory-like responses to prevent or diminish damage, leading to greater survival of mosquitoes after injection with a lethal dose.

Compared to *E. coli*, *S. aureus* apparently produced lower damage levels to the mosquitoes. Despite the increased cecropin and defensin levels in the *S. aureus--S. aureus* group after the second injection, and the effective activity of these AMPs against Gram-positive bacteria ([@B26], [@B27]; [@B4]; [@B7]), their expression was not sufficient to enhance the survival of primed mosquitoes. Since *S. aureus* had a low effect on the integrity of vital host processes, if mosquitoes were infected with a higher dose they would likely not sense any notable increase in damage, meaning that the organism should not make any increased investment in immune response without a survival compensation. The activation of the immune transcriptional pathways may be influenced by several factors, including damage, recognition of the microorganism responsible for producing the damage, and a recovery threshold ([@B53]; [@B29]). After the lethal challenge, the increased expression of defensin activated by *S. aureus* was probably related to the degree of damage to the mosquito, but not to a real compensation in terms of survival. Our results also showed that injury itself (RPMI--RPMI group) could have an impact on the survival, but not in AMPs expression. We hypothesize that mosquito cannot control damage without pathogen sensing. The immune response is turned off when pathogen and damage reach a threshold level where negative effects are "insignificant" and when no more danger molecules (self or non-self) are produced ([@B8]). Probably, the damage, without the bacteria, produces an impairment of the regulation of the immune response (ROS, PO but not AMP as figures showed) decreasing mosquitoes survival. Endogenous damage-associated molecular patterns (DAMPs) or danger signals associated with tissue damage can induce innate trained immunity through epigenetic regulation of transcriptional programs ([@B36]). According to the danger model, damage to tissues induce the release of DAMPs, allowing the proper type and level intensity of the immune response against a certain pathogen ([@B11]).

This trained immunity induced by previously encountered pathogens may also help to respond rapidly and appropriately to the next challenge. However, it seems that in *A. aegypti* the concurrence of damage and the pathogen leaded to an optimal immune response. Several DAMPs have been found in insects ([@B30]). It will be very interesting to determine the DAMPs particularly involved in the *A. aegypti*'s priming against bacteria.

Pathogen presence over several generations could be also required to generate a proper recognition and therefore an investment in priming ([@B5]). In the wild, the microbiota of *A. aegypti* is mostly constituted by Gram-negative bacteria ([@B56]; [@B41]). Therefore, it is possible that the mosquito is prone to a priming response when interacting with *E. coli* or other Gram-negative bacteria, while investment in priming and enhanced immunity could be quite costly in relation to the interaction between the mosquito and an uncommon Gram positive bacterium (such as *S. aureus*). The non-expression of attacin in the interaction between the mosquito and *S. aureus* could be related to the specificity of immunity, and particularly to the cost of production of attacin in response or to an infrequent gram+ bacterium (*S. aureus*). However, this explanation needs further research.

In summary, we have provided evidence for a quasi-specific injury and infection priming in *A. aegypti* at the AMP transcriptional level. However, molecular priming in this study did not always correlate with increased mosquito survival. It is likely that investment in the immune response depends on several factors, including pathogen virulence, level of infection, host damage, pathogen presence over several generations, and frequency of contact with the pathogen in the microenvironment of an insect. The mechanisms of immune response in insects include reactions and molecules that are interconnected. Therefore, we cannot exclude the possibility that the memory-like response also depended on cellular activity and/or other humoral molecules not measured herein. The present results suggest that not all the immune effectors may undergo a simultaneous increase in response to pathogens. Priming against bacteria seems to rely on the molecules released after damage (DAMPs) caused by infection, the level of protection afforded against future infections, and probably the prevalence of a pathogen across generations.
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